2744
G. B. Dharma Rao et al. / Tetrahedron Letters 53 (2012) 2741–2744
13. Banerjee, A.; Mukherjee, A. K. Stain Technol. 1981, 56, 83.
(400 MHz, DMSO-d6) d = 5.932 (s, 1H), 6.082 (s, 1H), 6.965 (m, 2H), 7.119 (m,
1H), 7.337–7.359 (m, 2H), 7.427–7.451 (m, 2H), 7.519 (s, 1H), 7.880–7.903 (m,
2H). 13C NMR (DMSO-d6) d = 53.170, 113.410, 113.860, 114.077, 114.738,
114.945, 116.837, 122.833, 122.858, 122.983, 125.119, 127.450, 128.846,
130.430, 131.105, 145.427, 147.557, 149.204, 160.954, 163.388. ESI-MS: m/
z = 294.671 [M+1].
14. (a) Sirkeeioglu, O.; Talinli, N.; Akar, A. J. Chem. Res. (S) 1995, 502; (b) Ahmad,
M.; King, T. A.; Ko, D.-K.; Cha, B. H.; Lee, J. J. Phys. D: Appl. Phys. 2002, 35, 1473.
15. Knight, C. G.; Stephens, T. Biochem. J. 1989, 258, 683.
16. Lambert, R. W.; Martin, J. A.; Merrett, J. H.; Parkes, K. E. B.; Thomas, G. J. Chem.
Abstr. 1997, 126, p212377y.
17. Hideo, T. Jpn. Tokkyo Koho JP 56005480, 1981; Chem. Abstr. 1981, 95, 80922b.
18. Poupelin, J. P.; Saint-Rut, G.; Foussard-Blanpin, O.; Narcisse, G.; Uchida-Ernouf,
G.; Lacroix, R. Eur. J. Med. Chem. 1978, 13, 67.
19. Saint-Ruf, G.; De, A.; Hieu, H. T. Bull. Chim. Ther. 1972, 7, 83–86.
20. Ion, R. M.; Frackowiak, D.; Planner, A.; Wiktorowicz, K. Acta Biochim. Pol. 1998,
45, 833–845.
21. (a) Bigdeli, M. A.; Heravi, M. M.; Mahdavinia, G. H. Catal. Commun. 2007, 8,
1595; (b) Maleki, B.; Gholizadeh, M.; Sepehr, Z. Bull. Korean Chem. Soc. 2011, 32,
1697–1702; (c) Mirjalili, B. B. F.; Bamoniri, A.; Akbari, A. Tetrahedron Lett. 2008,
49, 6454–6456; (d) Rajitha, B.; Kumar, B. S.; Reddy, Y. T.; Reddy, P. N.;
Sreenivasulu, N. Tetrahedron Lett. 2005, 46, 8691.
1-(4-Ethoxyphenyl)-1H-naphtho[1,2-e][1,3]oxazin-3(2H)-one 4g: mp 216–218,
IR (m
Max): 812, 921, 1178, 1223, 1400, 1513, 1722, 2977, 3128, 3240. 1H NMR
(400 MHz, CDCl3) d = 1.363 (t, J = 7.2 Hz, 3H), 3.926 (q, J = 7.2 Hz, 2H), 6.025 (s,
1H), 6.644 (s, 1H), 6.780–6.802 (m, 2H), 7.146–7.175 (m, 2H), 7.257–7.853 (m,
6H). 13C NMR (CDCl3) d = 14.721, 55.393, 63.438, 112.910, 115.130, 117.051,
122.955, 125.132, 127.366, 128.236, 128.742, 129.394, 130.376, 131.001,
133.862, 147.522, 150.625, 159.011. ESI-MS: m/z = 320.216 [M+1].
1-(4-(Trifluoromethyl)phenyl)-1H-naphtho[1,2-e][1,3]oxazin-3(2H)-one 4h: mp
234–236, IR (m
Max): 814, 1068, 1120, 1325, 1516, 1727, 1760, 3151, 3234. 1H
NMR (400 MHz, CDCl3) d = 6.154 (s, 1H), 6.798 (s, 1H), 7.343–7.912 (m, 10H).
13C NMR (CDCl3) d = 55.279, 111.717, 117.043, 122.346, 122.471, 125.051,
125.439, 126.394, 126.430, 126.467, 127.458, 127.750, 128.973, 129.083,
130.663, 131.007, 131.032, 145.247, 147.717, 150.474. ESI-MS: m/z = 344.08
[M+1].
22. Typical experimental procedure:
(a) A 25 ml round bottom flask was charged with benzaldehyde (1.0 equiv),
urea (2.0 equiv) and catalytic amount of ZnO-NPs (0.3 equiv). The reactants are
finely powdered and mixed together and allowed to stir for 30 min at room
temperature. The 2-naphthol (1.0 equiv) was added to the above mixture and
the resulting reaction mixture was heated at 150 °C (oil bath) with constant
stirring till the reaction was complete. After completion of reaction as
indicated on TLC, the reaction mixture was cooled to room temperature and
the crude reaction mixture was dissolved in ethylacetate and the catalyst was
separated out by simple filtration. The reaction mixture in ethylacetate was
washed with water and excess of solvent was removed under reduced
pressure. The solid mass was washed with cold diethylether (20 ml  2) and
dried. The pure product was obtained in 76–94% yield. (b) A mixture of
1-(4-(Trifluoromethoxy)phenyl)-1H-naphtho[1,2-e][1,3]oxazin-3(2H)-one 4i: mp
168–170, IR (mMax): 816, 923, 1175, 1224, 1262, 1512, 1739, 2968, 3140, 3226.
1H NMR (400 MHz, CDCl3) d = 6.117 (s, 1H), 6.865 (s, 1H), 7.139–7.160 (m, 2H),
7.259–7.515 (m, 6H), 7.846–7.898 (m, 2H). 13C NMR (CDCl3) d = 54.945,
112.154, 117.051, 119.072, 121.656, 122.645, 125.413, 127.699, 128.608,
128.946, 129.202, 130.876, 131.074, 140.196, 147.702, 149.179, 149.192,
150.765. ESI-MS: m/z = 360.481 [M+1].
14-(4-Ethoxyphenyl)-14H-dibenzo[a,j]xanthenes 5b: mp 172–174 °C, IR (mMax):
2976, 2905, 1591, 1510, 1397, 1244, 1044, 806. 1H NMR (400 MHz, CDCl3)
d = 1.255 (t, J = 6.8 Hz, 3H), 3.808 (q, J = 6.8 Hz, 2H), 6.418 (s, 1H), 6.645 (d,
J = 8.8 Hz, 2H), 7.404–7.367 (m, 4H), 7.465 (d, J = 8.8 Hz, 2H), 7.558–7.534 (m,
2H), 7.812–7.745 (m, 4H), 8.372 (d, 2H). 13C NMR (CDCl3) d = 14.643, 37.025,
63.034, 114.266, 117.479, 117.880, 122.650, 124.084, 126.609, 128.593,
128.676, 129.047, 130.987, 131.358, 137.111, 148.562, 157.167.
aldehyde (1.0 equiv) and 2-naphthol (2.0 equiv) was charged in
a round
bottom flask. A catalytic amount of ZnO-NPs (0.3 equiv) was added and the
reaction was heated at 120 °C (oil bath) with constant stirring under solvent-
free condition for certain period of time as required. The progress of the
reaction was monitored by TLC. After completion of reaction, the reaction
mixture was cooled to room temperature. The reaction mixture was dissolved
in ethylacetate and the catalyst was separated out by simple filtration. Excess
of solvent was removed under reduced pressure and the crude product was
recrystallized with ethanol to afford the pure product in 80–92% yield. The
spectral data for some selected compounds are given below.
14-(4-Ethylphenyl)-14H-dibenzo[a,j]xanthenes 5g: mp 186–188 °C, IR (mMax):
2961, 2927, 1592, 1513, 1399, 1244, 961, 806. 1H NMR (400 MHz, CDCl3)
d = 1.045 (t, J = 7.6 Hz, 3H), 2.411 (q, J = 7.6 Hz, 2H), 6.428 (s, 1H), 6.947 (d,
J = 8.0 Hz, 2H), 7.350–7.390 (m, 4H), 7.411 (d, J = 8.0 Hz, 2H), 7.439–7.561 (m,
2H), 7.793–7.730 (m, 4H), 8.381 (d, 2H). 13C NMR (CDCl3) d = 15.021, 28.136,
37.532, 117.468, 117.908, 122.679, 124.086, 126.622, 127.845, 128.027,
128.630, 128.671, 130.993, 131.421, 141.986, 142.216, 148.656.
1-(3-Fluorophenyl)-1H-naphtho[1,2-e][1,3]oxazin-3(2H)-one 4d: mp 218–220, IR
(m
Max): 794, 929, 1184, 1226, 1397, 1487, 1756, 2966, 3132, 3216. 1H NMR